Secarna Pharmaceuticals Enters Into Cooperation with Guangzhou’s Sun Yat-sen University to Develop a Treatment for SARS-CoV-2 Viral Infections
Secarna to develop LNAplusTM-based antisense oligonucleotides which specifically suppress the expression of a certain host factor essential to the SARS-CoV-2...